What to expect: Same obesity indication, different molecule (semaglutide → tirzepatide). Restart titration from Zepbound 2.5 mg. Allow 4-6 weeks of GI adjustment.
Washout window: ~7 days for Wegovy to clear
Why patients switch from Wegovy to Zepbound
- Greater weight-loss potential — SURMOUNT-1 ~22% vs STEP-1 ~15%
- Wegovy plateau after 6-12 months
- Insurance shifted preferred formulary to Zepbound
- Better GI tolerability reported by some patients on tirzepatide
- Wegovy shortage during 2022-2024 driving supply switch
Side effects during the Wegovy → Zepbound transition
- Nausea/vomiting peak in weeks 2-4
- Constipation (more common on tirzepatide)
- Brief appetite return in week 1
- Possible 1-3 lb weight regain during titration restart
Discuss with your prescriber before switching
This guide is editorial — not medical advice. Switching GLP-1 medications must be supervised. Bring this checklist to your appointment:
- Required — switch must be prescriber-supervised
- If history of pancreatitis or gallbladder disease
- If GI symptoms severe past week 4
Dose conversion: Wegovy → Zepbound
Use this table as a starting reference only. Final dose depends on your tolerance, weight-loss trajectory, and prescriber guidance. Never self-titrate based on a chart.
| Wegovy dose | Zepbound dose | Note |
|---|---|---|
| Any | Restart titration from lowest dose | Different mechanism (semaglutide → tirzepatide). No direct conversion. |
Transition timeline
Plan on 2-week prep + 12-week evaluation window. Most weight-loss outcomes can be re-assessed at the 12-week mark on the new medication.
Week −2: Decision + prescriber alignment
Confirm with your prescriber: dose-equivalent target, expected side-effect profile differences (semaglutide → tirzepatide), insurance implications.
Week −1: Last Wegovy dose
Continue your current Wegovy schedule. Wegovy has a long half-life — semaglutide ~1 week, tirzepatide ~5 days — so effects persist for days after stopping.
Week 0: First Zepbound dose
Restart titration from lowest Zepbound dose. Overlap effect possible in the first 7-10 days as Wegovy clears.
Weeks 1-4: Stabilization
Side-effect profile shifts. GI symptoms (nausea, constipation) may be more pronounced. Track weight + appetite.
Weeks 4-12: Re-evaluation
Compare outcomes to your Wegovy baseline. If weight-loss trajectory hasn't improved by week 12, discuss whether the switch was right.
Beyond 12 weeks
If outcomes good, continue. If switch underperformed Wegovy, discuss reverting or trying a third option (often semaglutide-based).
FAQ — Wegovy → Zepbound
Can I take Wegovy and Zepbound together?
No. Combining GLP-1 medications isn't done outside clinical trials. Stop Wegovy before starting Zepbound; the long half-lives mean overlap occurs naturally.
Will I lose ground when switching from Wegovy to Zepbound?
Possibly temporarily. Most patients maintain weight during a clean switch when restart dose is appropriate. The bigger risk is regression if the switch fails to match Wegovy efficacy. Plan and 12-week evaluation window.
Does insurance cover Zepbound if it covered Wegovy?
Different molecule means different formulary placement. Run a fresh prior authorization for Zepbound — coverage of Wegovy doesn't transfer automatically.
How long does Wegovy stay in my system after the last dose?
Semaglutide has a ~1-week half-life — effects taper over 4-5 weeks after the last injection. Plan your Zepbound start timing accordingly.
Cost comparison
Cash-pay pricing differs significantly between Wegovy and Zepbound. Run the true-cost calculator with your insurance details for an apples-to-apples comparison including coupons and patient assistance programs. Open true cost calculator →
Provider match
Find a provider that offers Zepbound
Continuity of care matters during a switch. We compared 12+ telehealth providers ranked by Zepbound availability, price, and prescriber accessibility.
See top Zepbound providers →Affiliate disclosure: we earn commission on provider sign-ups. Learn more
Next steps
Before switching, read our full Wegovy review and Zepbound review. For provider options that carry both medications, see our Wegovy vs Zepbound comparison and Wegovy alternatives hub.
Sources
Not medical advice. Switching GLP-1 medications must be done with prescriber supervision. This guide is editorial summary based on published prescribing information and clinical guidance. Full medical disclaimer.